Ratings by Leerink (Faisal A. Khurshid)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/5/2025 | Geron Corporation | GERN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/22/2025 | Galapagos NV | GLPG | Upgrade | Outperform (Market Perform) |
34.39 (27.73) |
-19.37% | Details | |
| 10/15/2025 | ANI Pharmaceuticals | ANIP | Maintain | Outperform (N/A) |
|
Details | ||
| 10/10/2025 | MannKind | MNKD | New Coverage | Outperform (N/A) |
5.14 (3.91) |
-23.93% | Details | |
| 9/25/2025 | Contineum Therapeutics | CTNM | New Coverage | Outperform (N/A) |
10.50 (15.49) |
47.52% | Details | |
| 8/14/2025 | Zura Bio Ltd. | ZURA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2025 | ANI Pharmaceuticals | ANIP | Maintain | Outperform (N/A) |
|
Details | ||
| 4/30/2025 | Immunic Inc. | IMUX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/14/2025 | Ironwood Pharmaceuticals | IRWD | Maintain | Market Perform (N/A) |
|
Details | ||
| 3/25/2025 | Zura Bio Ltd. | ZURA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/10/2025 | Trevi Therapeutics | TRVI | Maintain | Outperform (N/A) |
|
Details | ||
| 3/3/2025 | Pliant Therapeutics | PLRX | Downgrade | Market Perform (Outperform) |
3.44 (1.04) |
-69.77% | Details | |
| 2/28/2025 | ANI Pharmaceuticals | ANIP | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2025 | Ironwood Pharmaceuticals | IRWD | Maintain | Market Perform (N/A) |
|
Details | ||
| 12/11/2024 | ANI Pharmaceuticals | ANIP | New Coverage | Outperform (N/A) |
59.16 (79.24) |
33.94% | Details | |
| 11/4/2024 | Zura Bio Ltd. | ZURA | New Coverage | Outperform (N/A) |
4.38 (5.43) |
23.97% | Details | |
| 10/11/2024 | Geron Corporation | GERN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/9/2024 | MannKind | MNKD | New Coverage | Outperform (N/A) |
5.93 (5.14) |
-13.32% | Details | |
| 9/9/2024 | Pliant Therapeutics | PLRX | New Coverage | Outperform (N/A) |
12.87 (1.04) |
-91.92% | Details | |
| 9/9/2024 | Trevi Therapeutics | TRVI | New Coverage | Outperform (N/A) |
2.95 (18.25) |
518.64% | Details | |
| 9/9/2024 | Immunic Inc. | IMUX | New Coverage | Outperform (N/A) |
1.34 (13.97) |
942.54% | Details | |
| 9/9/2024 | Ironwood Pharmaceuticals | IRWD | New Coverage | Market Perform (N/A) |
4.51 (4.23) |
-6.21% | Details | |
| 9/9/2024 | Geron Corporation | GERN | New Coverage | Outperform (N/A) |
4.25 (1.29) |
-69.65% | Details |
